Diagnostics
New study data show that monitoring blood levels of sphingotec’s endothelial function biomarker bio-ADM(R) on top of guideline parameter lactate improves risk stratification of sepsis patients admitted to intensive care units
The global home diagnostics market is witnessing a growth and shall continue to expand at a high pace on account of the rising disposable income of people across nations, which enable them to afford products that enable self care.
Bioactive Adrenomedullin is a biomarker for endothelial dysfunction and allows the prediction of septic shock as elevated blood levels of bio-ADM(R) predict blood pressure break down and blood vessel leakage resulting in edema
Now that global responses are fully mobilized, what is being done to identify and develop drugs and vaccines against this novel coronavirus?
Vela Diagnostics Submitting Novel Coronavirus Diagnostic Test to FDA for Emergency Use Authorization
Vela Diagnostics has developed the ViroKeyTM SA201 COVID-19 RT-PCR Test, a new diagnostic test for the detection of the COVID-19 coronavirus. Vela Diagnostics is currently in discussions with the U.S. Food and Drug Administration for clearance of the test under the emergency use authorization.
There’s a growing demand for life sciences professionals in Massachusetts, but a new report indicates that the home-grown talent pipeline is not adequate enough to meet the growing demands in the Bay State.
The most recent figure for the China coronavirus outbreak is 28,018 confirmed cases with 563 deaths in China. Chinese health authorities indicate 19 foreigners have been infected by the virus. There are reports that a Chinese newborn is the youngest person to become infected. The infant was diagnosed 30 hours after birth, apparently having gotten it from the mother.
What if you could detect cancer just as it is getting started? New research published in the journal Nature just might give medicine the tools to do just that.
GENOMICA, a wholly owned company of PharmaMar Group, is developing a kit to reliably detect and identify the new virus known as “Wuhan pneumonia”.
The spreading of the coronavirus that began in Wuhan, China has researchers and health officials worldwide studying the emerging virus and preparing to treat it and develop vaccines. With such an enormous global focus, it seems that new information about the virus and the infection is being published each day.
PRESS RELEASES
